Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 225 of 3173 entries
View as:

CPG 7909 in Patients Wih Stage IV Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00043407 Org: User:
Start: 03/31/02 End: 09/30/04 Due: 09/30/05

A Study Comparing the Plasma Drug Exposure of an Oral Dose of Palbociclib (PD-0332991) to an Intravenous Dose of Palbociclib (PD-0332991)

Phase: N/A Priority: Normal
NCT ID: NCT01802476 Org: User:
Start: 05/31/13 End: 06/30/13 Due: 06/30/14

Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00638313 Org: User:
Start: 08/31/07 End: 02/29/08 Due: 02/28/09

A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

Phase: N/A Priority: Normal
NCT ID: NCT00002304 Org: User:
Start: - End: - Due: -

"VIBRATIONS" - A Study In Smokers Who Are Willing And Motivated To Stop Smoking With The Aid Of Varenicline Which Will Be Prescribed According To Usual Clinical Practice In Germany

Phase: N/A Priority: Normal
NCT ID: NCT01104636 Org: User:
Start: 05/31/10 End: 03/31/11 Due: 03/31/12

Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)

Phase: N/A Priority: Normal
NCT ID: NCT02584634 Org: User:
Start: 12/18/15 End: 07/13/22 Due: 07/13/23

Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04412252 Org: User:
Start: 07/06/20 End: 10/18/20 Due: 10/18/21

Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT02114203 Org: User:
Start: 12/31/14 End: 09/30/16 Due: 09/30/17

Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01204112 Org: User:
Start: 09/30/10 End: 10/31/10 Due: 10/31/11

A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Phase: N/A Priority: Normal
NCT ID: NCT01371838 Org: User:
Start: 12/31/11 End: 05/31/13 Due: 05/31/14

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT04546425 Org: User:
Start: 09/09/20 End: 02/18/23 Due: 02/18/24

Co-Administration Of Methotrexate And CP-690,550

Phase: N/A Priority: Normal
NCT ID: NCT01745055 Org: User:
Start: 04/30/05 End: 06/30/06 Due: 06/30/07

A Hepatic Impairment Study for PF-04965842.

Phase: N/A Priority: Normal
NCT ID: NCT03626415 Org: User:
Start: 10/01/18 End: 04/30/19 Due: 04/30/20

A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.

Phase: N/A Priority: Normal
NCT ID: NCT05987072 Org: User:
Start: 11/03/23 End: 12/31/23 Due: 12/31/24

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02003924 Org: User:
Start: 10/31/13 End: 10/31/25 Due: 10/31/26

A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05687032 Org: User:
Start: 02/24/23 End: 11/07/25 Due: 11/07/26

Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide

Phase: N/A Priority: Normal
NCT ID: NCT05097716 Org: User:
Start: 11/02/21 End: 01/10/22 Due: 01/10/23

Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)

Phase: N/A Priority: Normal
NCT ID: NCT05382364 Org: User:
Start: 06/29/22 End: 12/31/25 Due: 12/31/26

Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT01033669 Org: User:
Start: 11/30/09 End: 02/28/10 Due: 02/28/11

Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan

Phase: N/A Priority: Normal
NCT ID: NCT05153187 Org: User:
Start: 08/31/19 End: 11/26/20 Due: 11/26/21

Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT01245387 Org: User:
Start: 08/31/06 End: 12/31/09 Due: 12/31/10

A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01513928 Org: User:
Start: 01/31/12 End: 02/29/12 Due: 02/28/13

A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02058277 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03850483 Org: User:
Start: 04/08/19 End: 04/20/21 Due: 04/20/22

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02504294 Org: User:
Start: 07/13/15 End: 07/16/16 Due: 07/16/17